Cargando…

Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients

Although serum thyroglobulin (Tg) is a reliable differentiated thyroid carcinoma (DTC) prognostic marker, its cutoff values can be affected by TSH stimulation status. Serum Tg prognostic values measured at different time points before and after radioactive iodine (RAI) therapy prepared with recombin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mutsuddy, Pupree, Jeon, Subin, Yoo, Su Woong, Zhang, Yingjie, Chowdhury, Md. Sunny Anam, Kim, Jahae, Song, Ho-Chun, Bom, Hee-Seung, Min, Jung-Joon, Kwon, Seong Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440056/ https://www.ncbi.nlm.nih.gov/pubmed/32243397 http://dx.doi.org/10.1097/MD.0000000000019652

Ejemplares similares

Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
por: Yoo, Su Woong, et al.
Publicado: (2020)

Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients
por: Kim, Jahae, et al.
Publicado: (2017)

Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy
por: Park, Hee Jeong, et al.
Publicado: (2017)

A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [(18)F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer
por: Piao, Hong Hua, et al.
Publicado: (2021)

Percentage change of primary tumor on (18)F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis: Comparison with MRI
por: Yoo, Jang, et al.
Publicado: (2017)

Stimulated Serum Thyroglobulin Levels versus Unstimulated Serum Thyroglobulin in the Follow-up of Patients with Papillary Thyroid Carcinoma
por: Sunny, Saumya Sara, et al.
Publicado: (2018)

A randomized, multi-center, open-label study to compare the safety and efficacy between afatinib monotherapy and combination therapy of afatinib and HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations
por: Song, Si-Yeon, et al.
Publicado: (2020)

Glucose metabolism of visceral adipose tissue measured by (18)F-FDG PET/CT is related to the presence of colonic adenoma
por: Yoon, Hai-Jeon, et al.
Publicado: (2017)

Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer
por: Byun, Byung Hyun, et al.
Publicado: (2013)

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer
por: Lee, Seul Gi, et al.
Publicado: (2016)

Coexistence of Papillary Thyroid Carcinoma With Thyroid MALT Lymphoma in a Patient With Hashimoto's Thyroiditis: A Clinical Case Report
por: Shen, Guohua, et al.
Publicado: (2015)

Thyroid metastasis from chondrosarcoma
por: Wu, Zhi-Hong, et al.
Publicado: (2019)

Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment
por: Werner, R.A., et al.
Publicado: (2015)

Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
por: Zahra, Hashem O., et al.
Publicado: (2021)

Evaluation of voice function after BABA robotic thyroid lobectomy: A comparative analysis with endoscopic thyroid lobectomy
por: Liu, Peigen, et al.
Publicado: (2022)

The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study
por: Zhu, Feng, et al.
Publicado: (2016)

THE MOLECULAR WEIGHT AND ISOELECTRIC POINT OF THYROGLOBULIN
por: Heidelberger, Michael, et al.
Publicado: (1935)

Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
por: Jeong, Eugene, et al.
Publicado: (2019)

Rapid disease progression after discontinuation of lenvatinib in thyroid cancer
por: Yamazaki, Haruhiko, et al.
Publicado: (2020)

Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients
por: Lu, Yi, et al.
Publicado: (2020)

Bioinformatics identify the role of chordin-like 1 in thyroid cancer
por: Yu, Jia-Wei, et al.
Publicado: (2023)

Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2021)

BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules
por: Sheng, Danli, et al.
Publicado: (2021)

Is it possible to predict hypothyroidism after thyroid lobectomy through thyrotropin, thyroglobulin, anti-thyroglobulin, and anti-microsomal antibody?
por: Cho, Jin Seong, et al.
Publicado: (2011)

The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/ Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
por: Demir, Fadime, et al.
Publicado: (2019)

Cancer-specific functional profiling in microsatellite-unstable (MSI) colon and endometrial cancers using combined differentially expressed genes and biclustering analysis
por: Na, Woong, et al.
Publicado: (2023)

Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial
por: Park, Kwonoh, et al.
Publicado: (2023)

Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review
por: Cai, Sina, et al.
Publicado: (2017)

The relationship between iodine intake and the risk of thyroid cancer: A meta-analysis
por: Cao, Ling-Zhi, et al.
Publicado: (2017)

Response to immunotherapy in a patient with anaplastic thyroid cancer: A case report
por: Zheng, Luming, et al.
Publicado: (2021)

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review
por: Ding, Ran, et al.
Publicado: (2023)

A case report of solitary fibrous tumor of the thyroid gland and literature review
por: Zhang, Jin, et al.
Publicado: (2023)

Evaluation of ABO/Rh blood group distributions in papillary thyroid cancer patients
por: Dogan, Ozlem
Publicado: (2023)

Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer
por: Zhang, Zhiqiang, et al.
Publicado: (2023)

Prognosis prediction of pancreatic cancer after curative intent surgery using imaging parameters derived from F-18 fluorodeoxyglucose positron emission tomography/computed tomography
por: Yoo, Min Young, et al.
Publicado: (2020)

Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
por: Li, Hongtao, et al.
Publicado: (2017)

A primary cavernous hemangioma of the thyroid gland: A case report and literature review
por: Miao, Jie, et al.
Publicado: (2017)

Anaplastic thyroid carcinoma combined with sclerosing mucoepidermoid carcinoma with eosinophilia: A case report
por: Mao, Ruiqi, et al.
Publicado: (2020)

The correlation between ultrasonographic features, bFGF, and the local invasiveness of thyroid papillary carcinoma
por: Jia, Zhi-Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qan2pbtq1p4fjsh5dab4saia6l